In India, the infant mortality rate (IMR) stands at 28 per 1,000 live births, with prematurity and undiagnosed conditions causing 60% of fetal deaths. CareNX Innovations has introduced Fetosense, an AI-based fetal heart monitoring solution that effectively reduces IMR by 52%. The device has been implemented in over 500 private hospitals and more than 10 government hospitals, facilitating early detection of high-risk pregnancies and enhancing maternal care. Fetosense is compact, battery-free, and enables remote monitoring via smartphones, making it cost-effective and time-saving, especially in low-resource settings like Primary Health Centres (PHCs) and Sub Centres. It aids in identifying fetal distress and ensures timely referrals. CareNX aims to expand this innovative technology throughout India. The patented wireless monitor requires no consumables or special expertise for field operation, with additional goals of decreasing mortality and morbidity while improving treatment in targeted health areas.